These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7797446)

  • 1. Production of the staurosporine aglycon K-252c with a blocked mutant of the staurosporine producer strain Streptomyces longisporoflavus and by biotransformation of staurosporine with Streptomyces mediocidicus ATCC 13279.
    Goeke K; Hoehn P; Ghisalba O
    J Antibiot (Tokyo); 1995 May; 48(5):428-30. PubMed ID: 7797446
    [No Abstract]   [Full Text] [Related]  

  • 2. The staurosporine producing strain Streptomyces longisporoflavus produces metabolites related to K-252a. Proposal for biosynthetic intermediates of K-252a.
    Cai Y; Fredenhagen A; Hug P; Peter HH
    J Antibiot (Tokyo); 1996 Oct; 49(10):1060-2. PubMed ID: 8968403
    [No Abstract]   [Full Text] [Related]  

  • 3. Further minor metabolites of staurosporine produced by a Streptomyces longisporoflavus strain.
    Cai Y; Fredenhagen A; Hug P; Meyer T; Peter HH
    J Antibiot (Tokyo); 1996 Jun; 49(6):519-26. PubMed ID: 8698633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nitro analogue of staurosporine and other minor metabolites produced by a Streptomyces longisporoflavus strain.
    Cai Y; Fredenhagen A; Hug P; Peter HH
    J Antibiot (Tokyo); 1995 Feb; 48(2):143-8. PubMed ID: 7706124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activities of indolocarbazole and bis-indole protein kinase C inhibitors.
    Sancelme M; Fabre S; Prudhomme M
    J Antibiot (Tokyo); 1994 Jul; 47(7):792-8. PubMed ID: 8071125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity.
    Osada H; Koshino H; Kudo T; Onose R; Isono K
    J Antibiot (Tokyo); 1992 Feb; 45(2):189-94. PubMed ID: 1556009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important role of a LAL regulator StaR in the staurosporine biosynthesis and high-production of Streptomyces fradiae CGMCC 4.576.
    Guan H; Li Y; Zheng J; Liu N; Zhang J; Tan H
    Sci China Life Sci; 2019 Dec; 62(12):1638-1654. PubMed ID: 31820200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of specific binding sites for [3H]-staurosporine on various protein kinases.
    Herbert JM; Seban E; Maffrand JP
    Biochem Biophys Res Commun; 1990 Aug; 171(1):189-95. PubMed ID: 2393390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-Demethoxy-3'-hydroxystaurosporine, a novel staurosporine analogue produced by a blocked mutant.
    Hoehn P; Ghisalba O; Moerker T; Peter HH
    J Antibiot (Tokyo); 1995 Apr; 48(4):300-5. PubMed ID: 7775266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.
    Rüegg UT; Burgess GM
    Trends Pharmacol Sci; 1989 Jun; 10(6):218-20. PubMed ID: 2672462
    [No Abstract]   [Full Text] [Related]  

  • 11. Potent and specific inhibitors of protein kinase C of microbial origin.
    Tamaoki T; Nakano H
    Biotechnology (N Y); 1990 Aug; 8(8):732-5. PubMed ID: 1370017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of indocarbazostatin B, incorporation of D-[U-13C] glucose and L-[2-13C] tryptophan.
    Feng Y; Mitsuhashi S; Kishimoto T; Ubukata M
    J Antibiot (Tokyo); 2005 Dec; 58(12):759-65. PubMed ID: 16506693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC.
    Mizuno K; Saido TC; Ohno S; Tamaoki T; Suzuki K
    FEBS Lett; 1993 Sep; 330(2):114-6. PubMed ID: 8365480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury.
    Goodman Y; Mattson MP
    Brain Res; 1994 Jul; 650(1):170-4. PubMed ID: 7953671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of staurosporine on histamine release from rat serosal mast cells.
    Kurosawa M; Okayama Y; Kobayashi S
    Ann Allergy; 1989 Sep; 63(3):231-4. PubMed ID: 2476049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic effects of epidermal growth factor on cultured brain neurons are blocked by protein kinase inhibitors.
    Abe K; Takayanagi M; Saito H
    Jpn J Pharmacol; 1992 Jun; 59(2):259-61. PubMed ID: 1434124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranes of human neuroblastoma SH-SY5Y cells contain specific binding sites for [3H]K-252A.
    Knight E; Connors TJ; Hudkins R; Maroney AC; Neff N
    Biochem Biophys Res Commun; 1995 Jun; 211(2):511-8. PubMed ID: 7794263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.
    White JR; Zembryki D; Hanna N; Mong S
    Biochem Pharmacol; 1990 Aug; 40(3):447-56. PubMed ID: 1696482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLR-52, (4'-demethylamino-4',5'-dihydroxystaurosporine), a new inhibitor of protein kinase C with immunosuppressive activity.
    McAlpine JB; Karwowski JP; Jackson M; Mullally MM; Hochlowski JE; Premachandran U; Burres NS
    J Antibiot (Tokyo); 1994 Mar; 47(3):281-8. PubMed ID: 7802863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of staurosporine, K 252a and other structurally related protein kinase inhibitors on shape and locomotion of Walker carcinosarcoma cells.
    Zimmermann A; Keller H
    Br J Cancer; 1992 Dec; 66(6):1077-82. PubMed ID: 1457347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.